Literature DB >> 19049980

SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells.

Mami Takahata1, Yasumichi Inoue, Hitoshi Tsuda, Issei Imoto, Daizo Koinuma, Makoto Hayashi, Takashi Ichikura, Takao Yamori, Koichi Nagasaki, Mika Yoshida, Masao Matsuoka, Kazuhiro Morishita, Keiko Yuki, Aki Hanyu, Keiji Miyazawa, Johji Inazawa, Kohei Miyazono, Takeshi Imamura.   

Abstract

Chromosomal amplification occurs frequently in solid tumors and is associated with poor prognosis. Several reports demonstrated the cooperative effects of oncogenic factors in the same amplicon during cancer development. However, the functional correlation between the factors remains unclear. Transforming growth factor (TGF)-beta signaling plays important roles in cytostasis and normal epithelium differentiation, and alterations in TGF-beta signaling have been identified in many malignancies. Here, we demonstrated that transcriptional co-repressors of TGF-beta signaling, SKI and MDS1/EVI1-like gene 1 (MEL1), were aberrantly expressed in MKN28 gastric cancer cells by chromosomal co-amplification of 1p36.32. SKI and MEL1 knockdown synergistically restored TGF-beta responsiveness in MKN28 cells and reduced tumor growth in vivo. MEL1 interacted with SKI and inhibited TGF-beta signaling by stabilizing the inactive Smad3-SKI complex on the promoter of TGF-beta target genes. These findings reveal a novel mechanism where distinct transcriptional co-repressors are co-amplified and functionally interact, and provide molecular targets for gastric cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19049980     DOI: 10.1074/jbc.M808989200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.

Authors:  Ian Toma; Timothy A McCaffrey
Journal:  Cell Tissue Res       Date:  2011-05-31       Impact factor: 5.249

2.  Identification of Ski as a target for Aurora A kinase.

Authors:  Jocelyn Mosquera; Ricardo Armisen; Hongling Zhao; Diego A Rojas; Edio Maldonado; Julio C Tapia; Alicia Colombo; Michael J Hayman; Katherine Marcelain
Journal:  Biochem Biophys Res Commun       Date:  2011-05-12       Impact factor: 3.575

Review 3.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

4.  The role of DNA methylation in human trophoblast differentiation.

Authors:  Teena K J B Gamage; William Schierding; Daniel Hurley; Peter Tsai; Jackie L Ludgate; Chandrakanth Bhoothpur; Lawrence W Chamley; Robert J Weeks; Erin C Macaulay; Joanna L James
Journal:  Epigenetics       Date:  2018-12-05       Impact factor: 4.528

5.  Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.

Authors:  Hariom Yadav; Celia Quijano; Anil K Kamaraju; Oksana Gavrilova; Rana Malek; Weiping Chen; Patricia Zerfas; Duan Zhigang; Elizabeth C Wright; Christina Stuelten; Peter Sun; Scott Lonning; Monica Skarulis; Anne E Sumner; Toren Finkel; Sushil G Rane
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

6.  c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasion.

Authors:  Liyang Wang; Yixuan Hou; Yan Sun; Liuyang Zhao; Xi Tang; Ping Hu; Jiajia Yang; Zongyue Zeng; Guanglun Yang; Xiaojiang Cui; Manran Liu
Journal:  Mol Oncol       Date:  2013-08-27       Impact factor: 6.603

7.  Quantitative Proteomics of the SMAD (Suppressor of Mothers against Decapentaplegic) Transcription Factor Family Identifies Importin 5 as a Bone Morphogenic Protein Receptor SMAD-specific Importin.

Authors:  Roy Baas; Ayestha Sijm; Hetty A A M van Teeffelen; Robert van Es; Harmjan R Vos; H Th Marc Timmers
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

Review 8.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

9.  Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.

Authors:  BaoHan T Vo; Bianca Cody; Yang Cao; Shafiq A Khan
Journal:  Carcinogenesis       Date:  2012-07-27       Impact factor: 4.944

Review 10.  DNA and histone methylation in gastric carcinogenesis.

Authors:  Danielle Queiroz Calcagno; Carolina Oliveira Gigek; Elizabeth Suchi Chen; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.